CSP #599: Transfusion Trigger After Operations in High Cardiac Risk Patients (TOP) - VA Cooperative Studies Program (CSP)
Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

VA Cooperative Studies Program (CSP)

Menu
Menu

Quick Links

Veterans Crisis Line Badge
My healthevet badge
 

CSP #599: Transfusion Trigger After Operations in High Cardiac Risk Patients (TOP)

 

Investigator Access

What's Available




Check with the study contact and publications for information on a public dataset, data archive, data enclave, or website where data might be available.

Available Documentation

Dates Data are Available

Access Criteria

Study Characteristics

Objectives

To determine whether a liberal transfusion strategy (transfusion trigger at Hb < 10 gm/dl) in Veterans at high cardiac risk who undergo major open vascular and general surgery operations is associated with decreased risk of adverse postoperative outcomes compared to a restrictive transfusion strategy (transfusion trigger at Hb < 7 gm/dl).

Era of Service

All

Population

Inclusion Criteria

  • Males and females older than 18 years of age who have postoperative Hb < 10 gm/dl within 15 days after the index operation
  • Patients who undergo an operation in either one of the three following categories, regardless of their preoperative Hb level, and regardless of preoperative or intraoperative transfusion they might have received:
       o  Veterans who undergo peripheral artery disease (PAD)-related operations
       o  Veterans with past medical history of ischemic stroke or ischemic heart disease (IHD) or PAD who undergo general surgery procedures
       o  Veterans with past medical history of ischemic stroke or IHD or PAD who undergo Vascular Surgery operations

Exclusion Criteria

  • Unable to consent or unwilling to follow protocol, such as Jehovah’s witnesses
  • Known history of hereditary anemias such as Thalassemia or Sickle cell disease; known history of hereditary bleeding disorders, such as factor VIII or factor IX deficiency; or prior history of adverse reaction to blood administration, such as fever, rash, or hemolysis
  • Doesn’t speak or understand English
  • Hemodynamically unstable or in cardiogenic shock
  • Participating in another interventional trial whose objective is to evaluate the effect of transfusion on outcomes, or prior randomization in CSP #599
  • Pregnancy 
  • Prisoner or in custody of law enforcement

Study Design

Randomized, intent-to-treat, two-arm, parallel design, single-blind, multicenter trial

Time Period

2018 – 2022

Setting

National (15 VA Medical Centers)

N

3,070 participants

Response Rate

Recruitment ongoing

Recruitment Method

Unconfirmed

Compensation

Unconfirmed

Data Collected

  • Length of hospital stay
  • All-cause mortality at 1 year after randomization (myocardial infarction (MI), coronary revascularization, acute renal failure, or postoperative ischemic stroke)
  • A composite endpoint (up to 90 days after randomization) of:     
       o  All-cause post-randomization mortality
       o  MI
       o  Coronary revascularization
       o  Acute renal failure
       o  Post-randomization ischemic stroke
       o  New cardiac arrhythmias that necessitate new treatment
       o  New or worsening congestive heart failure (CHF)
       o  Cardiac arrest

Data Collection Methods

  • Assessments will be collected pre/post-operatively and at discharge, or at 30 days after randomization if the patient is still hospitalized
  • Follow up forms will be filled out during a clinic visit after the 30th and 90th post-randomization day. Patients who cannot present to the clinic will have a phone call for follow up
  • One year post-randomization mortality will be ascertained using electronic medical records, phone follow-up, and search of the national death index

Funding Source

VA Cooperative Studies Program (CSP)

Contact

Erin Norman, Leslie.Norman@va.gov

Selected Publications

Unconfirmed

More Information

ClinicalTrials.gov
ClinicalTrials.gov Identifier: NCT03229941
ClinicalTrials.ucsf.edu 1



1 This link takes you to a non-U.S. government website. VA isn't responsible for the content or privacy policies on that site and doesn't endorse the content or its sponsor.